Characterizing Survival for Patients Supported With Inotropes After the 2018 Donor Allocation Restructuring: A UNOS Database Analysis
Allocation policy revisions have contributed to increased utilization of temporary support (ECMO, tMCS, and IABP) and decreased utilization of others such as durable LVADs. Additionally, revisions have led to improved survival and increased transplantation for patients waitlisted on inotropes, yet similar survival for each individual form of temporary support.
Authors
- Vakhtang Tchantchaleishvili (ORCID: https://orcid.org/0000-0002-4357-3533)
- Eric D. Warner (ORCID: https://orcid.org/0000-0003-4753-1098)
- Christopher Pritting (ORCID: https://orcid.org/0000-0003-3842-4442)
- Indranee Rajapreyar (ORCID: https://orcid.org/0000-0003-2043-3789)
- Yevgeniy Brailovsky (ORCID: https://orcid.org/0000-0002-4811-5267)
- Joshua Chen (ORCID: https://orcid.org/0009-0005-6550-7448)
- Abdulmojeed Ekiyoyo
Institutions
- Tufts University (US)
- Cleveland Clinic (US)
- Thomas Jefferson University (US)
- Bayhealth Foundation (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/ctr.70105
- Primary Topic
- Organ Donation and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00